Author： Cooper J.L.
Publisher： Adis International
ISSN： 1170-229X
Source： Drugs & Aging, Vol.20, Iss.6, 2003-01, pp. : 399-418
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Apolipoprotein E and Alzheimers Disease: Therapeutic Implications
By Higuchi M.
CNS Drugs, Vol. 11, Iss. 6, 1999-06 ,pp. :
Access to resources
Recommend
The Glutamatergic System and Alzheimers Disease: Therapeutic Implications
By Butterfield D.A. Pocernich C.B.
CNS Drugs, Vol. 17, Iss. 9, 2003-01 ,pp. :
New concepts in the drug therapy of Alzheimer’s disease
By Farlow Martin R Hake Ann Marie
Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 12, 2001-12 ,pp. :
Hormone therapy and Alzheimer’s disease: benefit or harm?
Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. :
Editorial: Multitarget Molecules for Alzheimer's Disease Therapy
Current Topics in Medicinal Chemistry, Vol. 17, Iss. 31, 2018-02 ,pp. :